Announcements Trials
Browse Landscape

Phase

Phase 2/3 1Phase 2 1Phase 1 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 35Genitourinary 11Breast 11Classical hematology 9Thoracic 8Plasma cell 8Myeloid 7Gynecologic 6Tumor-Agnostic 4Head & Neck 3Dermatologic 3Sarcoma 2CNS 2Other solid neoplasm 1Other neoplasm 1Other hematologic neoplasm 1Other 1Lymphoid 1

Conditions

Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Head and Neck Neoplasms 1

Interventions

Cisplatin 416Radiotherapy 240Radiotherapy, Intensity-Modulated 178Cetuximab 177Docetaxel 166pembrolizumab 148Carboplatin 121Fluorouracil 113Paclitaxel 90Nivolumab 82Gemcitabine 82Radiation 72Surveys and Questionnaires 71Drug Therapy 70toripalimab 68Surgical Procedures, Operative 64Magnetic Resonance Spectroscopy 63Capecitabine 50Blood Specimen Collection 50Chemoradiotherapy 46Biopsy 44camrelizumab 41durvalumab 40Radiosurgery 40Standard of Care 38Erlotinib Hydrochloride 34nimotuzumab 32130-nm albumin-bound paclitaxel 32tislelizumab 31apatinib 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Aspirin × Head & Neck × Clear all
NCT03245489 2025-01-31

Anti-platelet + Pembro for H&N Tumors

Medical University of South Carolina

Phase 1 Completed
20 enrolled
Head & Neck

Head and Neck Neoplasms

NCT05865548 2024-08-13

Addition of Aspirin to Standard of Care in Oral Cancer

Banaras Hindu University

Phase 2/3 Completed
60 enrolled
Head & Neck

Mouth Neoplasms

NCT03290820 2017-10-26

Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients

Sun Yat-sen University

Phase 2 Unknown
184 enrolled
Head & Neck

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡